TREATMENT WITH ANAGRELIDE IN PATIENTS WITH POLYCYTHEMIA VERA

被引：0

作者：

Francisca, Ramis ^{[1
]}

Alicia, Senin ^{[1
]}

Ma Teresa, Gomez Casares ^{[2
]}

Juan Carlos, Hernandez Boluda ^{[3
]}

Encinas Manuel, Perez ^{[4
]}

Ma Jose, Ramirez ^{[5
]}

Ana, Kerguelen ^{[6
]}

Joaquin, Martinez ^{[7
]}

Jose M, Raya ^{[3
,8
]}

Carlos, Besses ^{[1
]}

Alberto, Alvarez-Larran ^{[1
]}

机构：

[1] UAB, Hosp Mar IMIM, Serv Hematol, Barcelona, Spain

[2] Hosp Dr Negrin, Serv Hematol, Las Palmas Gran Canaria, Spain

[3] Hosp Clin, Serv Hematol, Valencia, Spain

[4] Hosp Clin Univ, Serv Hematol, Santiago De Compostela, Spain

[5] Hosp Jerez, Serv Hematol, Jerez de la Frontera, Andalucia, Spain

[6] Hosp La Paz, Serv Hematol, Madrid, Spain

[7] Hosp 12 Octubre, Serv Hematol, Madrid, Spain

[8] Hosp Univ Canarias, Serv Hematol, Santa Cruz De Tenerife, Spain

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PC-184

引用

下载

页码：189 / 189

页数：1

共 50 条

[1] Anagrelide for treatment of high platelet count in patients with polycythemia vera
Petrone, ME
Tierney, DS
Mahoney, MP
Petitt, RM
Silverstein, MN
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 308 - 308
[2] Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera
Kremyanskaya, Marina
Mascarenhas, John
Hoffman, Ronald
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (08) : 1185 - 1194
[3] Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment
Hultdin, Magnus
Sundstrom, Gunnel
Wahlin, Anders
Lundstrom, Berith
Birgegard, Gunnar
Engstrom-Laurent, Anna
MEDICAL ONCOLOGY, 2007, 24 (01) : 63 - 70
[4] Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment
Magnus Hultdin
Gunnel Sundström
Anders Wahlin
Berith Lundström
Jan Samuelsson
Gunnar Birgegård
Anna Engström-Laurent
Medical Oncology, 2007, 24 : 63 - 70
[5] Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia
Jurgens, DJ
Moreno-Aspitia, A
Tefferi, A
BLOOD, 2004, 104 (11) : 424A - 424A
[6] Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia
Jurgens, DJ
Moreno-Aspitio, A
Tefferi, A
HAEMATOLOGICA, 2004, 89 (11) : 1394 - 1395
[7] Ruxolitinib for the treatment of patients with polycythemia vera
Kiladjian, Jean-Jacques
Winton, Elliott F.
Talpaz, Moshe
Verstovsek, Srdan
EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 391 - 401
[8] Treatment of polycythemia vera
Barbui, T
Finazzi, G
HAEMATOLOGICA, 1998, 83 (02) : 143 - 149
[9] TREATMENT OF POLYCYTHEMIA VERA
WASSERMAN, LR
GILBERT, HS
MEDICAL CLINICS OF NORTH AMERICA, 1966, 50 (06) : 1501 - +
[10] Treatment of polycythemia vera
Silver, Richard T.
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (04): : 437 - 442

← 1 2 3 4 5 →